Management of Neuroendocrine Tumors of the Rectum (rNET) Using Ga-68 Somatostatin Receptor PET/CT (SR-PET/CT) and Peptide Receptor Radionuclide Therapy (PRRT)

被引:0
|
作者
Prasad, V [1 ]
Kaemmerer, D. [1 ]
Hommann, M. [1 ]
Hoersch, D. [1 ]
Zachert, C. [1 ]
Baum, R. P. [1 ]
机构
[1] Zent Klin Bad Berka, Bad Berka, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
85
引用
收藏
页码:132 / 132
页数:1
相关论文
共 50 条
  • [1] Ga-68 somatostatin receptor PET/CT (SR-PET/CT) and peptide receptor radionuclide therapy (PRRT) for management of neuroendocrine tumors of the rectum (rNET)
    Prasad, V.
    Kaemmerer, D.
    Hoersch, D.
    Hommann, M.
    Zachert, C.
    Baum, R. P.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [2] Management of neuroendocrine tumours of the rectum (rNET) with Ga-68 somatostatin receptor PET/CT (SR-PET/CT) and Peptide Receptor Radionuclide Therapy (PRRT)
    Prasad, V.
    Kaemmerer, D.
    Hommann, M.
    Hoersch, D.
    Zachert, C.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S201 - S201
  • [3] Ga-68 somatostatin receptor PET/CT in the management of neuroendocrine tumors of the lungs
    Prasad, Vikas
    Pape, Ulrich-Frank
    Pavel, Marianne
    Wiedenmann, Bertram
    Brenner, Winfried
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [4] Patient Selection for Personalized Peptide Receptor Radionuclide Therapy Using Ga-68 Somatostatin Receptor PET/CT
    Kulkarni, Harshad R.
    Baum, Richard P.
    [J]. PET CLINICS, 2014, 9 (01) : 83 - +
  • [5] Theranostics with Ga-68 Somatostatin Receptor PET/CT Monitoring Response to Peptide Receptor Radionuclide Therapy
    Kulkarni, Harshad R.
    Baum, Richard P.
    [J]. PET CLINICS, 2014, 9 (01) : 91 - +
  • [6] Orbital Metastasis Detected by Ga-68 Somatostatin Receptor PET/CT in Patients with Neuroendocrine Tumors
    Awange, Z.
    Baum, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S687 - S687
  • [7] Ga-68 Somatostatin Receptor PET/CT in the Detection of Insulinoma
    Prasad, V
    Blankenstein, O.
    Ploeckinger, U.
    Pape, U. F.
    Pascher, A.
    Pavel, M.
    [J]. NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 114 - 114
  • [8] 68Ga-DOTATATE PET/CT to predict response to peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumours (NETs).
    Sharma, Rohini
    Wang, Wai Meng
    Evans, Joanne
    Yusuf, Siraj
    Ai-Nahhas, Adil
    Mauri, Francesco
    Barwick, Tara
    Aboagye, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Does Molecular Response Assessment after Peptide Receptor Radionuclide Therapy using Ga-68 Somatostatin Receptor PET/CT Offer an Additional Benefit?
    Kulkarni, H. R.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S200 - S200
  • [10] Detection of unknown primary in patients with neuroendocrine tumors (NET) using Ga-68 somatostatin receptor (SR) PET/CT: Results in 129 patients
    Prasad, Vikas
    Kaemmerer, Daniel
    Settmacher, U.
    Hoersch, Dieter
    Hommann, Merten
    Baum, Richard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52